IL-6 mediates 11βhsd type 2 to effect progression of the mycobacterial cord factor trehalose 6,6′-dimycolate-induced granulomatous response

NeuroImmunoModulation

Volumn 18, Issue 4, 2011, Pages 212-225

  Abbott, April N ^a   Welsh, Kerry J ^c,d   Hwang, Shen An ^c   Płoszaj, Paulina ^e   Choudhury, Tina ^c   Boyd, Sydney ^c   Blackburn, Michael R ^b,c,d   Hunter Jr , Robert L ^c,d   Actor, Jeffrey K ^c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

11 hydroxysteroid dehydrogenase; Granuloma; Inflammation; Lung; Mycobacterial glycolipid

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORD FACTOR; CORTICOSTERONE; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID RELEASE; CORTICOSTERONE BLOOD LEVEL; CYTOKINE RESPONSE; DISEASE COURSE; ENZYME INDUCTION; ENZYME REGULATION; FEMALE; GENE DISRUPTION; LUNG GRANULOMATOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CORD FACTORS; CORTICOSTERONE; CYTOKINES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULOMA, RESPIRATORY TRACT; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79952352702     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000323776     Document Type: Article

References (60)

1. World Health Organization, Global tuberculosis control: WHO report 2010. Geneva. World Health Organization, 2010.
2. Dye C, et al: Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 2008; 8: 233-243.
3. Flynn JL, et al: Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-572.
4. Actor JK, et al: Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis. J Interferon Cytokine Res 1999; 19: 1183-1193. (Pubitemid 29502786)
5. Russell DG: Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007; 5: 39-47. (Pubitemid 44942302)
6. Ulrichs T, Kaufmann SH: New insights into the function of granulomas in human tuberculosis. J Pathol 2006; 208: 261-269. (Pubitemid 43126118)
7. Egen JG; et al: Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 2008; 28: 271-284.
8. Russell DG, Barry CE 3rd, Flynn JL: Tuberculosis: what we don't know can, and does, hurt us. Science 2010; 328: 852-856.
9. Calcagni E, Elenkov I: Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann NY Acad Sci 2006; 1069: 62-76. (Pubitemid 43989851)
10. Webster JI, Sternberg EM: Role of the hypothalamic- pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol 2004; 181: 207-221. (Pubitemid 38744671)
11. Bottasso O, et al: The immuno-endocrine component in the pathogenesis of tuberculosis. Scand J Immunol 2007; 66: 166-175. (Pubitemid 47063193)
12. Bottasso O, et al: Immunoendocrine alterations during human tuberculosis as an integrated view of disease pathology. Neuroimmunomodulation 2009; 16: 68-77.
13. Mahuad C, et al: Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Neuroimmunomodulation 2007; 14: 193-199. (Pubitemid 350249117)
14. Barnes PJ: How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006; 148: 245-254. (Pubitemid 43804814)
15. Algood HM, Lin PL, Flynn JL: Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis, 2005; 41(suppl 3):S189-S193. (Pubitemid 41022089)
16. Welsh KJ, et al: A role for tumour necrosis factor-alpha, complement C5 and interleukin- 6 in the initiation and development of the mycobacterial cord factor trehalose 6,6 -dimycolate induced granulomatous response. Microbiology 2008; 154: 1813-1824.
17. Chakravarty SD, et al: Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect Immun 2008; 76: 916-926. (Pubitemid 351428050)
18. Saunders BM, et al: Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000; 68: 3322-3326. (Pubitemid 30340426)
19. Tait AS, Butts CL, Sternberg EM: The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol 2008; 84: 924-931.
20. Hernandez-Pando R, et al: Emergent immunoregulatory properties of combined glucocorticoid and anti-glucocorticoid steroids in a model of tuberculosis. QJMed 1998; 91: 755-766. (Pubitemid 28508622)
21. Howard AD, Zwilling BS: Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol 1999; 115: 428-434. (Pubitemid 29130356)
22. Rook G, et al: Local regulation of glucocorticoid activity in sites of inflammation. Insights from the study of tuberculosis. Ann NY Acad Sci 2000; 917: 913-922.
23. Yamagami H, et al: Trehalose 6,6′ -dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivitytype granulomas in mice. Infect Immun 2001; 69: 810-815. (Pubitemid 32109543)
24. Behling CA, et al: Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann Clin Lab Sci 1993; 23: 256-266. (Pubitemid 23213402)
25. Perez RL, et al: Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6′ - dimycolate. J Interferon Cytokine Res 2000; 20: 795-804.
26. Actor JK, et al: Mycobacterial glycolipid cord factor trehalose 6,6′ -dimycolate causes a decrease in serum cortisol during the granulomatous response. Neuroimmunomodulation 2002; 10: 270-282. (Pubitemid 36649363)
27. Ozeki Y, et al: In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′ -dimycolate). Infect Immun 1997; 65: 1793-1799. (Pubitemid 27193602)
28. Actor JK, et al: Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis . Comb Chem High Throughput Screen 2000; 3: 343-351.
29. Draper N, Stewart PM: 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 2005; 186: 251-271. (Pubitemid 41167396)
30. Abbott AN, et al: 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6′ -dimycolate. Neuroimmunomodulation 2009; 16: 147-154.
31. Guidry TV, et al: Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6′ - dimycolate. J Interferon Cytokine Res 2004; 24: 362-371. (Pubitemid 38781695)
32. Chi V, Chandy GK: Immunohistochemistry: paraffin sections using the Vectastain ABC kit from Vector Labs. J Vis Exp 2007; 8: 308.
33. Abbott AN, et al: 11β -hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6′ - dimycolate. Neuroimmunomodulation 2009; 16: 147-154.
34. T method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
35. Guidry TV, Hunter RL Jr, Actor JK: CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6′ -dimycolate in mice. Microbiology 2006; 152: 3765-3775. (Pubitemid 46040695)
36. Indrigo J, Hunter RL Jr, Actor JK: Influence of trehalose 6,6′ -dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 2002; 148: 1991-1998. (Pubitemid 34785283)
37. Indrigo J, Hunter RL Jr, Actor JK: Cord factor trehalose 6,6′ -dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 2003; 149: 2049-2059. (Pubitemid 37038411)
38. Seckl JR, Walker BR: 11β -hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol Metab 2004; 15: 418-424. (Pubitemid 39440724)
39. Rook GA, Hernandez-Pando R: Pathogenetic role, in human and murine tuberculosis, of changes in the peripheral metabolism of glucocorticoids and antiglucocorticoids. Psychoneuroendocrinology 1997; 22(suppl 1):S109-S113. (Pubitemid 27380703)
40. Rook GA, Hernandez-Pando R: The pathogenesis of tuberculosis. Annu Rev Microbiol 1996; 50: 259-284. (Pubitemid 26337464)
41. Hernandez-Pando R, et al: The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology 1998; 95: 234-241. (Pubitemid 28459387)
42. Paige C, Bishai WR: Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Cell Microbiol 2010; 12: 301-309.
43. Tsai MC, et al: Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 2006; 8: 218-232. (Pubitemid 43356045)
44. Rhoades ER, Frank AA, OrmeI M: Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis . Tuber Lung Dis 1997; 78: 57-66. (Pubitemid 28019788)
45. Ladel CH, et al: Lethal tuberculosis in interleukin- 6-deficient mutant mice. Infect Immun 1997; 65: 4843-4849. (Pubitemid 27463266)
46. Perez RL, et al: Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6′ -dimycolate. Am J Respir Crit Care Med 1994; 149: 510-518.
47. Van Snick J: Interleukin-6: an overview. Annu Rev Immunol 1990; 8: 253-278. (Pubitemid 20135628)
48. Ishihara K, HiranoT: IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev, 2002; 13: 357-368.
49. Dienz O, Rincon M: The effects of IL-6 on CD4 T cell responses. Clin Immunol 2009; 130: 27-33.
50. Elenkov IJ, et al: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12: 255-269. (Pubitemid 41318209)
51. Romano M, et al: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-325. (Pubitemid 27148598)
52. Clahsen T, Schaper F: Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J Leukoc Biol 2008; 84: 1521-1529. (Pubitemid 352774487)
53. Fattori E, et al: Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994; 180: 1243-1250. (Pubitemid 24289598)
54. Turnbull AV, et al: Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice. Endocrinology 2003; 144: 1894-1906. (Pubitemid 36543329)
55. Rey AD, et al: Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 2007; 21: 171-179.
56. Bottasso O, Morales-Montor J: Neuroimmunomodulation during infectious diseases: mechanisms, causes and consequences for the host. Neuroimmunomodulation 2009; 16: 65-67.
57. Suzuki S, et al: Dexamethasone upregulates 11β -hydroxysteroid dehydrogenase type 2 in BEAS-2B cells. Am J Respir Crit Care Med 2003; 167: 1244-1249. (Pubitemid 36555097)
58. Suzuki S, et al: Inflammatory mediators down-regulate 11β -hydroxysteroid dehydrogenase type 2 in a human lung epithelial cell line BEAS-2B and the rat lung. Tohoku J Exp Med 2005; 207: 293-301. (Pubitemid 41800004)
59. Ignatova ID, et al: Tumor necrosis factor-α upregulates 11β -hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-β in HepG2 cells. Am J Physiol Endocrinol Metab 2009; 296:E367-E377.
60. Rook GA, Baker R, Zumla A: Steroid metabolism and immunity: therapeutic implications. BioDrugs 1997; 8: 157-163. (Pubitemid 27366059)